Position in TEVA
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$4,874,518
+$587,117 QoQ
Shares Held
143,876
+1.1% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#195
of 671 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $6,951,552 across 44 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (70.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
143,876 | $4,874,518 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,544 | $836,585 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
3,008 | $506,968 | |
| 4 | ZTS |
Zoetis Inc.
|
2,994 | $215,148 | |
| 5 | LQDA |
Liquidia Corp
|
950 | $75,743 | |
| 6 | CTOR |
Citius Oncology, Inc.
|
107,424 | $69,825 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
447 | $49,590 | |
| 8 | VTRS |
Viatris Inc
|
2,398 | $38,080 |
All Filings in TEVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,874,518 | 143,876 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $4,287,401 | 142,344 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $4,315,437 | 138,271 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $13,958 | 691 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $11,832 | 706 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $10,620 | 691 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $88,137 | 3,999 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $36,742 | 2,039 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $2,291 | 141 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,989 | 141 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $1,472 | 141 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $11,638 | 1,141 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $13,915 | 1,848 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $10,947 | 1,237 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $28 | 869 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $12,105 | 1,500 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $9,091 | 1,209 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $9,361 | 997 | Shares | Sole | 2022-08-08 | |
| 2021-12-31 | $7,985 | 997 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $329,377 | 33,817 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $486,307 | 49,122 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $412,058 | 35,707 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $277,022 | 28,707 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $8,118 | 901 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $23,685 | 1,921 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $258,139 | 28,746 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||